Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Cash from Financing Activities (2016 - 2026)

Integra Lifesciences Holdings' Cash from Financing Activities history spans 17 years, with the latest figure at $24.3 million for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities rose 440.45% to $24.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $28.3 million, a 88.09% decrease, with the full-year FY2025 number at $28.3 million, down 88.09% from a year prior.
  • Cash from Financing Activities hit $24.3 million in Q4 2025 for Integra Lifesciences Holdings, up from -$10.2 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for IART hit a ceiling of $358.7 million in Q1 2024 and a floor of -$162.7 million in Q1 2023.
  • Historically, Cash from Financing Activities has averaged -$15.7 million across 5 years, with a median of -$10.5 million in 2023.
  • Biggest five-year swings in Cash from Financing Activities: crashed 18852.21% in 2022 and later soared 440.45% in 2025.
  • Tracing IART's Cash from Financing Activities over 5 years: stood at $521000.0 in 2021, then crashed by 18852.21% to -$97.7 million in 2022, then soared by 92.95% to -$6.9 million in 2023, then fell by 3.77% to -$7.2 million in 2024, then soared by 440.45% to $24.3 million in 2025.
  • Business Quant data shows Cash from Financing Activities for IART at $24.3 million in Q4 2025, -$10.2 million in Q3 2025, and -$21.1 million in Q2 2025.